Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;127(5):806-814.
doi: 10.1002/jso.27188. Epub 2023 Jan 6.

Treatment and survival of patients with metachronous colorectal lung metastases

Pernilla Hansdotter  1   2 , Peter Scherman  3   4 , Maziar Nikberg  5 , Sune H Petersen  6 , Erik Holmberg  7 , Magnus Rizell  3   8 , Peter Naredi  3   9 , Ingvar Syk  1   2 ; COLOFOL study group
Affiliations

Treatment and survival of patients with metachronous colorectal lung metastases

Pernilla Hansdotter et al. J Surg Oncol. 2023 Apr.

Abstract

Introduction: The lungs are the second most common site for metachronous metastases in colorectal cancer. No treatment algorithm is established, and the role of adjuvant chemotherapy is unclear. This study aimed to map pulmonary recurrences in a modern multimodal treated population, and to evaluate survival depending on management.

Methods: Retrospective study based on the COLOFOL-trial population of 2442 patients, radically resected for colorectal cancer stage II-III. All recurrences within 5 years were identified and medical records were scrutinized.

Results: Of 165 (6.8%) patients developing lung metastases as first recurrence, 89 (54%) were confined to the lungs. Potentially curative treatment was possible in 62 (37%) cases, of which 33 with surgery only and 29 with surgery and chemotherapy combined. The 5-year overall survival (5-year OS) for all lung recurrences was 28%. In patients treated with chemotherapy only the 5-year OS was 7.5%, compared with 55% in patients treated with surgery, and 72% when surgery was combined with chemotherapy. Hazard ratio for mortality was 2.9 (95% confidence interval 1.40-6.10) for chemotherapy only compared to surgery.

Conclusion: A high proportion of metachronous lung metastases after colorectal surgery were possible to resect, yielding good survival. The combination of surgery and chemotherapy might be advantageous for survival.

Keywords: follow-up; lung recurrence; prognosis; risk factors.

PubMed Disclaimer

References

REFERENCES

    1. Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467-1480.
    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
    1. Birgisson H, Talbäck M, Gunnarsson U, Påhlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol. 2005;31(8):845-853.
    1. Swedish colorectal cancer registry (SCRCR). Sveriges Kommuner och regioner. May 11, 2021. https://skr.se/en/kvalitetsregister/hittaregister/registerarkiv/tjockoch...
    1. Filip S, Vymetalkova V, Petera J, et al. Distant metastasis in colorectal cancer patients-do we have new predicting clinicopathological and molecular biomarkers? A comprehensive review. Int J Mol Sci. 2020;21(15):5255.

LinkOut - more resources